OTC Self-Care Device Market Counts TENS As Growth Predictor
This article was originally published in The Pink Sheet
Executive Summary
Sales of self-care devices for pain, allergies and cold sores are on the rise, with the pain treatment category growing double digits as consumers seek non-drug alternatives. Kline Group analyst Laura Mahecha discusses prospects of the devices, which are anticipated to take up more retail shelf space in coming years.
You may also be interested in...
Cialis Or Viagra Switch? Sanofi Survey, Pfizer Help Wanted Ad Could Be Signs
Viagra marketer Pfizer also could have nonprescription sales in sight as it recruits a "global sexual health" brand manager with responsibilities including shepherding market expansion through an Rx-to-OTC switch.
Bayer Shoulders Marketing Spend To Lift Consumer Product Sales
Headwinds for the consumer products business included support for launching ClariSpray and promoting the July introduction of Aleve Direct Therapy device for lower back pain.
Icy Hot SmartRelief Latest TENS Target Is Back Pain
Chattem rolls out Icy Hot SmartRelief Back & Hip device for drug-free pain relief for sore or aching muscles, chronic pain and arthritis, the Sanofi subsidiary says. The Back & Hip and Knee & Shoulder products feature the same control unit but different electrode pads, with refills sold without a control unit.